Quoin Pharmaceuticals
QNRX
10 hedge funds and large institutions have $128K invested in Quoin Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
25% more funds holding
Funds holding: 8 → 10 (+2)
0.26% more ownership
Funds ownership: 5.27% → 5.53% (+0.26%)
30% less capital invested
Capital invested by funds: $183K → $128K (-$55.5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$26.8K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$17K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.2K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$7.98K |
| 5 |
Two Sigma Investments
New York
|
+$7.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$29K |
| 2 |
HF
HRT Financial
New York
|
-$28K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$10.2K |
| 4 |
Renaissance Technologies
New York
|
-$8.94K |
QNRX Hedge Fund Activity: Q2 2024 in Review
10 of the 6,937 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q2 2024, worth a combined $128K — down 30% from $183K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new QNRX positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Altium Capital Management, adding an estimated $26.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $29K sold.
- 10 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q2 2024, up from 8 in Q1 2024.
- Funds reported $128K of Quoin Pharmaceuticals stock for Q2 2024, down 30% quarter-over-quarter.
- 5 funds opened new Quoin Pharmaceuticals positions in Q2 2024 and 3 closed out, a net change of +2 holders.
- The largest Quoin Pharmaceuticals buyer in Q2 2024 was Altium Capital Management, an estimated $26.8K added.
- The largest Quoin Pharmaceuticals seller in Q2 2024 was Virtu Financial, an estimated $29K sold.
Based on aggregated 13F filings for Q2 2024.